We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LUMO market cap is 24.24M. The company's latest EPS is USD -4.1980 and P/E is -0.21.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 497k | 512k | 691k | 527k | 7k |
Operating Income | -7.55M | -8.84M | -8.04M | -9.64M | -8.93M |
Net Income | -7.25M | -8.25M | -7.35M | -8.93M | -8.3M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 936k | 168k | 230k | 1.52M | 2.05M |
Operating Income | -45.13M | -26.3M | -31.35M | -32.04M | -36.61M |
Net Income | -42.99M | -5.66M | -30.43M | -31.06M | -34.03M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 79.21M | 72.29M | 63.73M | 56.37M | 47.75M |
Total Liabilities | 11.5M | 12.71M | 11.21M | 12.71M | 12.26M |
Total Equity | 67.71M | 59.58M | 52.52M | 43.66M | 35.49M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 96.79M | 129.03M | 100.31M | 72.29M | 40.64M |
Total Liabilities | 17.91M | 12.46M | 11.34M | 12.71M | 13.33M |
Total Equity | 78.88M | 116.57M | 88.98M | 59.58M | 27.31M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -20.8M | -26.62M | -9.2M | -15.88M | -23.7M |
Investing | N/A | -11.36M | -2.46M | -1.38M | 4.57M |
Financing | -346k | -821k | -309k | -883k | -1.32M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -30.21M | -23M | -29.65M | -26.62M | -31.1M |
Investing | 77k | 116.65M | 25.97M | -11.36M | 10.74M |
Financing | -59k | 75k | -192k | -821k | -576k |
Market Cap | 24.24M |
Price to Earnings Ratio | -0.21 |
Price to Sales Ratio | 3.52 |
Price to Cash Ratio | 0.21 |
Price to Book Ratio | 0.26 |
Dividend Yield | - |
Shares Outstanding | 8.11M |
Average Volume (1 week) | 61.61k |
Average Volume (1 Month) | 26.44k |
52 Week Change | -4.47% |
52 Week High | 4.55 |
52 Week Low | 2.41 |
Spread (Intraday) | 0.11 (3.55%) |
Company Name | Lumos Pharma Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://lumos-pharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions